Brand Post March 26, 2025 NYCRC ANNOUNCES ISSUANCE OF I-829 PETITION APPROVALS IN ALL 21 OF ITS EB-5 OFFERINGS New York, NY, March 26, 2025 (GLOBE NEWSWIRE) — With the issuance of the first I-829 petition approvals to EB-5…
Brand Post March 26, 2025 Latest Abstrax Analysis Uncovers a Missing Fatty Acid and New Flavor Balancing Esters in Cheese Cultivars Abstrax continues to reshape the science of cannabis flavors, spotlighting new compounds that challenge long-held assumptions about what makes cannabis…
Brand Post March 26, 2025 XRPTurbo Presale Soars Past 200,000 XRP, Announces Launchpad Demo & XRT Liquid Staking Platform TALLINN, Estonia, March 26, 2025 (GLOBE NEWSWIRE) — Excitement is reaching fever pitch in the XRP community as XRPTurbo, the…
Brand Post March 26, 2025 INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Walgreens Boots Alliance, Inc. and Certain Officers – WBA NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against…
Brand Post March 26, 2025 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in The Bancorp, Inc. of Class Action Lawsuit and Upcoming Deadlines – TBBK NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against…
Brand Post March 26, 2025 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MRVI NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against…
Brand Post March 26, 2025 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ready Capital Corporation of Class Action Lawsuit and Upcoming Deadlines – RC NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against…
Brand Post March 26, 2025 Aligos Therapeutics Presents Positive Data at APASL 2025 SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical…
Brand Post March 26, 2025 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AppLovin Corporation of Class Action Lawsuit and Upcoming Deadlines – APP NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against…
Brand Post March 26, 2025 Pentec Expands into Digital Therapeutic Services Through Partnership with Luminopia BOOTHWYN, Pa., March 26, 2025 (GLOBE NEWSWIRE) — Pentec Health, Inc., a leading complex care provider, delivers specialty pharmacy and…
Brand Post March 26, 2025 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. – HQY NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc…
Brand Post March 26, 2025 TransUnion’s TruValidate™ Solutions for Government Assessed FedRAMP Ready Key identity verification and fraud prevention product completes its FedRAMP Ready Assessment in Q1 2025 CHICAGO, March 26, 2025 (GLOBE…